BMRNBIOMARIN PHARMACEUTICAL INC
CUSIP 09061G101 · common stock · Other share classes: 09061GAK7
8 tracked investors held BIOMARIN PHARMACEUTICAL INC (BMRN) at the end of Q3 2026, worth $2.2B in total. The largest holder was PRIMECAP Management, with 0.6% of its portfolio. Lee Ainslie opened a new position this quarter.
Holders · Q3 2026
8
New holders
1
Value held
$2.2B
Quarter-end price (est.)
$60.00
Investors holding BMRN · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| PRIMECAP Management PRIMECAP Management Co | 0.56% | 14,988,996 | $899.3M | ADD+5.6% |
| Dodge & Cox Dodge & Cox | 0.47% | 14,625,740 | $877.5M | REDUCE-1.5% |
| Andreas Halvorsen Viking Global Investors LP | 1.32% | 7,173,173 | $430.4M | REDUCE-5.8% |
| Torray Funds Torray Investment Partners LLC | 0.58% | 73,615 | $4.4M | REDUCE-5.3% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.13% | 51,200 | $3.1M | ADD+4.5% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.00% | 25,474 | $1.5M | REDUCE-11.1% |
| Mario Gabelli GAMCO Investors, Inc. | 0.00% | 6,000 | $360K | REDUCE-53.8% |
| Lee Ainslie Maverick Capital Ltd | 0.00% | 4,088 | $245.3K | NEW |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Ken Fisher | 0.00% | 35,389 | $2M | EXIT |